Research Impact

h-index

N/A

Research impact score

Publications

0

Total publications

Trial Results

0

Published trial results

Citations

0

Total citations

Drug Portfolio

Analytics

Trial Phases

Phase 31

Trial Status

Terminated1

Role Distribution

Principal Investigator1
PI Rate100%

Activity Timeline

Clinical Trials (1)

NCT00991939Phase 3Terminated
Initial Treatment of Patients With Immune Thrombocytopenic Purpura
Immune Thrombocytopenic Purpura
Principalinvestigator

Research Network

Collaboration Network

25 collaborators·66 connections
Network Legend
KOL
Current Investigator
CO
High-influence Collaborator
CO
Collaborator
Click: view details
Double-click: go to profile
Drag: move node

Research Areas & Affiliations

Affiliations

The University of Oklahoma

Similar Key Opinion Leaders

Discover other key opinion leaders with similar research profiles, therapeutic areas, and collaboration networks.

10 similar investigators found

Xiaohui Zhang, md

Peking University People's Hospital, Peking University Insititute of Hematology

Moderately Similar
5 trials

Shared therapeutic areas:

Purpura, Thrombocytopenic, Idiopathic
Similarity Score30%

Mohsen S Elalfy, professor

Ain Shams University

Moderately Similar
4 trials

Shared therapeutic areas:

Purpura, Thrombocytopenic, Idiopathic
Similarity Score30%

heng Mei

Union Hospital, Tongji Medical College, Huazhong University of Science and Technology

Moderately Similar
7 trials

Shared therapeutic areas:

Purpura, Thrombocytopenic, Idiopathic
Similarity Score30%

William Wegener, MD, PhD

Gilead Sciences

Moderately Similar
12 trials

Shared therapeutic areas:

Purpura, Thrombocytopenic, Idiopathic
Similarity Score30%

Ming Hou, Dr

Shandong University

Moderately Similar
6 trials

Shared therapeutic areas:

Purpura, Thrombocytopenic, Idiopathic
Similarity Score30%

Yoshitaka Shimizu

Kissei Pharmaceutical Co., Ltd.

Moderately Similar
8 trials

Shared therapeutic areas:

Purpura, Thrombocytopenic, Idiopathic
Similarity Score30%

Xiao-Hui Zhang, MD

Peking University Institute of Hematology, Peking University People's Hospital

Moderately Similar
8 trials

Shared therapeutic areas:

Purpura, Thrombocytopenic, Idiopathic
Similarity Score30%

Shawn d St. Peter, MD

Children's Mercy Hospital Kansas City

Moderately Similar
14 trials

Shared therapeutic areas:

Purpura, Thrombocytopenic, Idiopathic
Similarity Score30%

Heng Mei, Ph.D&M.D

Union Hospital, Tongji Medical College, Huazhong University of Science and Technology

Moderately Similar
5 trials

Shared therapeutic areas:

Purpura, Thrombocytopenic, Idiopathic
Similarity Score30%

Ming Hou, Dr.

Shandong University

Moderately Similar
7 trials

Shared therapeutic areas:

Purpura, Thrombocytopenic, Idiopathic
Similarity Score30%

Publications (0)

No publications found for this investigator.

Clinical Trials (1)

Showing 1 of 1 trials

NCT00991939Phase 3PrincipalInvestigator

Initial Treatment of Patients With Immune Thrombocytopenic Purpura

Immune Thrombocytopenic Purpura
Terminated

All 1 trials loaded